U.K. Drug Experts Wanted GSK's Avandia Withdrawn In July, But EU Processes Intervened
EU regulators will discuss the fate of GlaxoSmithKline's Avandia at an extraordinary meeting on Sept. 8, but a decision is not expected until the end of the month.
EU regulators will discuss the fate of GlaxoSmithKline's Avandia at an extraordinary meeting on Sept. 8, but a decision is not expected until the end of the month.